New Insights into Endometrial Cancer 2022
This open access Special Issue brings together original research and review articles on molecular oncology, with attention given to endometrial cancer. It highlights new findings, methods, and technical advances in molecular cancer research. The main feature of this Special Issue is that it is a pla...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_101338 | ||
| 005 | 20230714 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230714s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-7914-6 | ||
| 020 | |a 9783036579153 | ||
| 020 | |a 9783036579146 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-7914-6 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a MJCL |2 bicssc | |
| 100 | 1 | |a Paleari, Laura |4 edt | |
| 700 | 1 | |a Paleari, Laura |4 oth | |
| 245 | 1 | 0 | |a New Insights into Endometrial Cancer 2022 |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (178 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This open access Special Issue brings together original research and review articles on molecular oncology, with attention given to endometrial cancer. It highlights new findings, methods, and technical advances in molecular cancer research. The main feature of this Special Issue is that it is a platform for open-source sharing of significant works in the field of molecular oncology that can increase our understanding of endometrial cancer development, which may lead to the discovery of new molecular diagnostic technologies and targeted therapeutics.Topics include:Molecular methods to personalize endometrial cancer screening and detection;Identification and new aspects of cellular signaling molecules and pathways for target discovery, drug design, and personalized and gender medicine;DDI discovery in endometrial cancer management;Drug repurposing for endometrial cancer prevention/treatment;Molecular modeling studies. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Oncology |2 bicssc | |
| 653 | |a endometrial cancer | ||
| 653 | |a TET proteins | ||
| 653 | |a O-GlcNAc transferase | ||
| 653 | |a TWIST1 | ||
| 653 | |a ZEB1 | ||
| 653 | |a FOXC1 | ||
| 653 | |a migration | ||
| 653 | |a invasion | ||
| 653 | |a lipotoxicity | ||
| 653 | |a palmitate | ||
| 653 | |a adjuvant chemotherapy | ||
| 653 | |a mass spectrometry | ||
| 653 | |a serum proteome | ||
| 653 | |a Suprabasin | ||
| 653 | |a 2D-DIGE | ||
| 653 | |a Western blotting | ||
| 653 | |a lymph node | ||
| 653 | |a metastasis | ||
| 653 | |a epithelial-to-mesenchymal transition | ||
| 653 | |a leave one out cross validation | ||
| 653 | |a signaling pathways | ||
| 653 | |a uterine neoplasm | ||
| 653 | |a cancer of the endometrium | ||
| 653 | |a spectroscopy | ||
| 653 | |a Raman spectroscopy | ||
| 653 | |a Fourier transform infrared spectroscopy | ||
| 653 | |a diagnosis | ||
| 653 | |a screening | ||
| 653 | |a racial disparity | ||
| 653 | |a molecular profiling | ||
| 653 | |a proteomic | ||
| 653 | |a TCGA | ||
| 653 | |a endometrial carcinoma | ||
| 653 | |a mismatch-repair | ||
| 653 | |a p53 | ||
| 653 | |a molecular | ||
| 653 | |a prognosis | ||
| 653 | |a treatment | ||
| 653 | |a histotype | ||
| 653 | |a POLE | ||
| 653 | |a microsatellite | ||
| 653 | |a diagnostic markers | ||
| 653 | |a prognostic gene | ||
| 653 | |a protein-ligand interactions | ||
| 653 | |a NRAS gene | ||
| 653 | |a hypoxia | ||
| 653 | |a tumor microenvironment (TME) | ||
| 653 | |a risk model | ||
| 653 | |a immune cells | ||
| 653 | |a chemotherapy | ||
| 653 | |a targeted treatment | ||
| 653 | |a EphA2 | ||
| 653 | |a Wee1 | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7433 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/101338 |7 0 |z DOAB: description of the publication |